CSIMarket



Adc Therapeutics Sa  (ADCT)
Other Ticker:  
 
 

ADCT's Free Cash Flow Growth by Quarter and Year

Adc Therapeutics Sa's Free Cash Flow results by quarter and year




ADCT Free Cash Flow (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December -460.87 -336.77 -4.20 13.70
III Quarter September - - 7.60 -22.40
II Quarter June - - 60.60 53.60
I Quarter March - - 40.50 45.30
FY   -460.87 -336.77 104.50 90.20



ADCT Free Cash Flow forth quarter 2021 Y/Y Growth Comment
Adc Therapeutics Sa in the forth quarter 2021 recorded free cash outflow of $ -460.87 millions.

According to the results reported in the forth quarter 2021, Adc Therapeutics Sa achieved the best Free Cash Flow growth in Major Pharmaceutical Preparations industry. While Adc Therapeutics Sa' s Free Cash Flow no change of % ranks overall at the positon no. in the forth quarter 2021.




ADCT Free Cash Flow ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - -62.77 %
III Quarter September - - - -
II Quarter June - - 13.06 % 37.79 %
I Quarter March - - -10.6 % 101.33 %
FY   - - 15.85 % -6.04 %

Financial Statements
Adc Therapeutics Sa's forth quarter 2021 Free Cash Flow $ -460.87 millions ADCT's Income Statement
Adc Therapeutics Sa's forth quarter 2020 Free Cash Flow $ -336.77 millions Quarterly ADCT's Income Statement
New: More ADCT's historic Free Cash Flow Growth >>


ADCT Free Cash Flow (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - -87.46 % -
II Quarter June - - 49.63 % 18.32 %
I Quarter March - - 195.62 % 23.1 %
FY (Year on Year)   - - 15.85 % -6.04 %




Free Cash Flow forth quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Free Cash Flow forth quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Free Cash Flow by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Adc Therapeutics Sa's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ADCT's IV. Quarter Q/Q Free Cash Flow Comment


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ADCT's IV. Quarter Q/Q Free Cash Flow Comment


Adc Therapeutics Sa's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Dec 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(March 30, 2010)
12 Months Ending
(Dec 31, 2009)
12 Months Ending
(Sep. 30, 2009)
Cumulative Free Cash Flow 12 Months Ending $ -457.44 $ -335.97 $ 104.50 $ 122.40 $ 92.40
Y / Y Free Cash Flow Growth (TTM) - - 15.85 % 8.03 % -30.79 %
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) - - -14.62 % 32.47 % 8.2 %
Seq. Free Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Free Cash Flow growth Comment
Adc Therapeutics Sa' has realized cumulative trailing twelve months free cash outflow of $ -457 millions in the Dec 31 2021 period.
The results are detiriorating as the cumulative free cash outflow is becoming larger from $ 0 millions in the twelve months ending a quarter before and $ 0 millions for the twelve months ending in the quarter Sep. 30, 2009.

Adc Therapeutics Sa achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Free Cash Flow growth Comment
Adc Therapeutics Sa' has realized cumulative trailing twelve months free cash outflow of $ -457 millions in the Dec 31 2021 period.
The situation is getting worse as the cumulative free cash outflow is getting bigger from $ 0 millions for the period from Dec 31 2020 to Sep. 30, 2009 and $ 0 millions for the twelve months ending in the quarter a year ago.

Adc Therapeutics Sa achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Free Cash Flow Growth
Major Pharmaceutical Preparations Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
ADCT's Free Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for ADCT's Competitors
Free Cash Flow Growth for Adc Therapeutics Sa's Suppliers
Free Cash Flow Growth for ADCT's Customers

You may also want to know
ADCT's Annual Growth Rates ADCT's Profitability Ratios ADCT's Asset Turnover Ratio ADCT's Dividend Growth
ADCT's Roe ADCT's Valuation Ratios ADCT's Financial Strength Ratios ADCT's Dividend Payout Ratio
ADCT's Roa ADCT's Inventory Turnover Ratio ADCT's Growth Rates ADCT's Dividend Comparisons



Companies with similar Free Cash Flow no change for the quarter ending Dec 31 2021 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Dec 31 2021
Syneos Health Inc 62.67%$ 62.674 millions
Lftd Partners Inc 62.43%$ 62.428 millions
Halozyme Therapeutics Inc 62.05%$ 62.050 millions
Collegium Pharmaceutical inc 60.33%$ 60.331 millions
Societal Cdmo Inc 56.50%$ 56.499 millions
Xoma Corporation55.94%$ 55.940 millions
Supernus Pharmaceuticals inc 52.70%$ 52.704 millions
Viemed Healthcare Inc 49.46%$ 49.456 millions
Catalyst Pharmaceuticals Inc 46.32%$ 46.319 millions
Icon Plc45.97%$ 45.967 millions
Meridian Bioscience Inc 41.53%$ 41.535 millions
Corcept Therapeutics Inc40.93%$ 40.934 millions
Charles River Laboratories International inc 39.19%$ 39.194 millions
United Therapeutics Corporation38.35%$ 38.352 millions
Vanda Pharmaceuticals Inc 37.85%$ 37.846 millions
Teva Pharmaceutical Industries Ltd37.76%$ 37.764 millions
Petmed Express Inc 35.23%$ 35.228 millions
Iradimed Corp34.85%$ 34.854 millions
Prestige Consumer Healthcare Inc 34.68%$ 34.676 millions
Emergent Biosolutions Inc 34.23%$ 34.231 millions
Antares Pharma Inc 33.63%$ 33.634 millions
Nature s Sunshine Products inc 32.53%$ 32.535 millions
Horizon Therapeutics Public Limited Company31.41%$ 31.414 millions
Amgen Inc 30.42%$ 30.423 millions
Resmed Inc 29.40%$ 29.405 millions
Tandem Diabetes Care Inc 28.86%$ 28.864 millions
Merck and Co Inc 27.18%$ 27.184 millions
Biodelivery Sciences International Inc 24.80%$ 24.800 millions
Astrazeneca Plc21.00%$ 20.996 millions
Eli Lilly And Company18.80%$ 18.802 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

EURN's Profile

Stock Price

EURN's Financials

Business Description

Fundamentals

Charts & Quotes

EURN's News

Suppliers

EURN's Competitors

Customers & Markets

Economic Indicators

EURN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071